Galapagos Stock

Galapagos OCF Margin

The Operating Cash Flow Margin of Galapagos (GLPG.AS) as of Aug 7, 2026 is -17.01 %. In the previous year, Operating Cash Flow Margin was -116.10 % — a change of -85.35% (higher).

OCF Margin

-17.01 %

YoY

-85.35%

Last updated:

Operating Cash Flow Margin of Galapagos is 2026 -17.01 % . Operating Cash Flow Margin of Galapagos was 2025 -116.10 % . It decreases by -85.35% higher compared to the previous year.
Access this data via the Eulerpool API

Galapagos Stock analysis

What does Galapagos do? Galapagos NV is a Belgian biopharmaceutical company focused on the development of novel drugs, particularly for autoimmune diseases and fibrosis. The company was founded in 1999 by Onno van de Stolpe and is headquartered in Mechelen, Belgium. Galapagos is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Galapagos stock

Operating Cash Flow Margin of Galapagos is -17.01 % in 2026.

Operating Cash Flow Margin of Galapagos changed from -116.10 % to -17.01 %, representing a -85.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Galapagos since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Galapagos with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Galapagos

All Key Metrics — Galapagos